Arthro Kinetics' Asian expansion gathers pace
This article was originally published in Clinica
Executive Summary
Arthro Kinetics (Esslingen, Germany) has made further progress in the Asian orthopaedics market by signing what the company has said to be the first major deals to commercialise its CaReS biologic cartilage regeneration products in the region. The orthopaedic regeneration product company this week inked an agreement with its joint venture partner, Arthro Anda Tianjin Biologic Technology to sell the product line in China, Taiwan and Hong Kong. The joint venture, of which Arthro Kinetics owns around 15%, was established in September 2006 for the production of CaReS using Arthro Kinetics' proprietary 3D collagen matrix for the surgical treatment of large area damage to the knee joint. The manufacturing facility, based in Tianjin, China, is scheduled to open at the end of 2008.